Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Ph...
FDA Recall #D-0023-2026 — Class III — October 9, 2025
Product Description
Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.
Reason for Recall
Labeling: Incorrect or Missing Lot and/or Exp Date
Recalling Firm
STAQ Pharma, Inc. — Denver, CO
Classification
Class III — Not likely to cause adverse health consequences.
Product Type
Drugs
Distribution
Nationwide in the U.S.
Code Information
Lot #: 25104595A, Expiry: 27DEC2025.
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated